HIGHLIGHTS
SUMMARY
Acute myocardial infarction (AMI) remains the leading cause of mortality worldwide. Recent registries indicate a growing population of patients suffering an acute coronary syndrome (ACS) without any SMuRF (SMuRF-less patients). Pro-inflammatory and atherosclerosis biomarkers, such as lipoprotein (a), C-reactive protein and fibrinogen, have been shown to have higher specificity in predicting worse prognosis of AMI in SMuRF-less patients, as compared to patients with SMuRFs, but no studies have been conducted to investigate their role as predictors of SMuRF-less AMIs. Pinpointing sensitive clinical and laboratory parameters, as well as diagnostic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.